Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PuraPharm Corp. Ltd. ( (HK:1498) ) has shared an announcement.
PuraPharm Corporation Limited announced a significant update regarding its proposed capital reduction and subdivision of unissued shares. The court in the Cayman Islands confirmed the capital reduction on January 28, 2025, and the process is now pending registration with the Registrar of Companies. Once registered, the capital reduction and subdivision will be effective, with new ordinary shares expected to commence trading on March 24, 2025. This move is expected to streamline the company’s share structure, potentially enhancing its market positioning and operational efficiency.
More about PuraPharm Corp. Ltd.
Average Trading Volume: 87,514
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$217.2M
Learn more about 1498 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- Ford Mustang Cobra Jet Fastest Electric Car on the Planet, Ford Stock (NYSE:F) Notches Up
- “…Overlook a Lack of Earnings Power”: UBS Analysts Target Intel Stock (NASDAQ:INTC), Stock Gains
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test